VEGFR
Os inibidores do Receptor do Fator de Crescimento Endotelial Vascular (VEGFR) são compostos que bloqueiam a sinalização do VEGFR, um receptor chave na via VEGF, crucial para a angiogênese. Os inibidores de VEGFR impedem a formação de novos vasos sanguíneos que fornecem nutrientes e oxigênio aos tumores, inibindo assim o crescimento tumoral. Esses inibidores são amplamente utilizados na terapia contra o câncer e na pesquisa para estudar os mecanismos da angiogênese e desenvolver tratamentos anticâncer. Na CymitQuimica, oferecemos uma ampla gama de inibidores de VEGFR de alta qualidade para apoiar sua pesquisa em oncologia, biologia vascular e angiogênese.
Foram encontrados 257 produtos para "VEGFR".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
PTC299
CAS:PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNAFórmula:C25H20Cl2N2O3Pureza:99.72%Cor e Forma:White SolidPeso molecular:467.34Ref: TM-T12574
1mg111,00€5mg230,00€1mL*10mM (DMSO)236,00€10mg350,00€25mg590,00€50mg838,00€100mg1.144,00€GW806742X
CAS:GW806742X inhibits MLKL with Kd 9.3 μM, preventing necroptosis; also targets VEGFR2.Fórmula:C25H22F3N7O4SPureza:98.3%Cor e Forma:SolidPeso molecular:573.55Lenvatinib
CAS:Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity.Fórmula:C21H19ClN4O4Pureza:98.46% - 99.96%Cor e Forma:White SolidPeso molecular:426.85Chloropyramine hydrochloride
CAS:Chloropyramine hydrochloride (Alergosan) is a histamine receptor H1 antagonist.Fórmula:C16H20ClN3·HClPureza:99.45% - 99.83%Cor e Forma:White SolidPeso molecular:326.26Sunitinib Malate
CAS:Sunitinib Malate (Sunitinib) is an indolinone-based tyrosine kinase inhibitor.Fórmula:C26H33FN4O7Pureza:98% - 99.26%Cor e Forma:SolidPeso molecular:532.56(E)-2-Cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
CAS:Fórmula:C25H30N2O2Pureza:98%Cor e Forma:SolidPeso molecular:390.5179Pazopanib
CAS:Pazopanib (GW786034) is an inhibitor of protein tyrosine kinases that inhibits VEGFR1/2/3. Pazopanib has antitumor activity. Cost-effective and quality-assured.Fórmula:C21H23N7O2SPureza:98.78% - 99.85%Cor e Forma:SolidPeso molecular:437.52ATWLPPR Peptide
CAS:ATWLPPR Peptide is a biologically active peptide functioning as a specific antagonist to VEGFR2/KDR.Fórmula:C40H61N11O9Peso molecular:839.98Conbercept
CAS:Conbercept (KH902) is a fusion protein comprising the second immunoglobulin C-like domain of FLT1 and the third and fourth immunoglobulin C-like domains of KDRPureza:98%Cor e Forma:LiquidProtein LMWP
CAS:Protein LMWP, a cell-penetrating peptide, exhibits inhibitory activity against vascular endothelial growth factor (VEGF), and is utilized in cancer research forFórmula:C72H142N44O16Pureza:98%Cor e Forma:SolidPeso molecular:1880.18Arginyl-Glutamine
CAS:Arginyl-Glutamine (Arg-Gln) is a dipeptide nutritional supplement that protects neonatal mice from hyperoxia-induced lung injury, lowering VEGF levels.Fórmula:C11H22N6O4Pureza:95.2%Cor e Forma:White SolidPeso molecular:302.33VGX100
VGX100 is a humanized antibody targeting VEGFC for the study of solid tumors.Pureza:98.6% (SDS-PAGE); 99.1% (SEC-HPLC) - 98.6% (SDS-PAGE); 99.1% (SEC-HPLC)Cor e Forma:LiquidPeso molecular:143.58 kDaGNQWFI
CAS:GNQWFI, an anti-Flt1 peptide, functions as a VEGFR1-specific antagonist. It inhibits interactions between VEGFR1 and various ligands, such as VEGFA, VEGFB, and placental growth factor (PIGF), and suppresses VEGF-induced endothelial cell migration and tubulogenesis. GNQWFI holds potential for research in cancer, asthma, and other ocular diseases.Fórmula:C37H49N9O9Cor e Forma:SolidPeso molecular:763.84KLTWQELYQLKYKGI
CAS:KLTWQELYQLKYKGI (QK) is a VEGF-mimicking peptide that competes with VEGF by binding to its receptors.Fórmula:C92H143N21O23Pureza:98%Cor e Forma:SolidPeso molecular:1911.25Pulocimab
CAS:Pulocimab, an anti-VEGFR2 monoclonal antibody (mAb), is utilized in cancer research [1].Cor e Forma:LiquidVEGFR-2-IN-55
VEGFR-2-IN-55 (Compound 30) is an effective VEGFR-2 kinase inhibitor with an IC50 of 1.24 nM and exhibits anti-tumor activity.Cor e Forma:Odour SolidRanibizumab
CAS:Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121,Pureza:98%Cor e Forma:Transparent LiquidPeso molecular:149.19KDVulinacimab
CAS:Vulinacimab is a mAb targeting VEGFR2 used to study angiogenesis mechanisms by blocking VEGF signaling.Pureza:95%Cor e Forma:Transparent LiquidAlacizumab pegol
CAS:Alacizumab pegol (CDP-791), a pegylated antibody fragment targeting KDR, is utilized in cancer research [1].
